Denka Company (4061) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
17 Mar, 2026Executive summary
Net sales for 1Q FY2025 were 94.1 billion yen, down 1.2% year-on-year, mainly due to sales price adjustments and a stronger yen, despite increased sales in electronics and innovative products.
Operating income declined 51.2% year-on-year to 2.3 billion yen, mainly due to inventory write-downs on chloroprene rubber.
Net income attributable to owners of parent rose 122.2% year-on-year to 5.0 billion yen, driven by an 8.2 billion yen gain on the sale of land for the Ofuna Plant, offsetting DPE-related losses.
Dividend forecast remains at 100 yen per share, with a total return ratio of 57%.
Financial highlights
Operating margin decreased to 2.4% from 5.0% year-over-year.
Ordinary income dropped to 1.7 billion yen from 3.6 billion yen year-over-year.
Gross profit for the quarter was 20.2 billion yen, down from 22.2 billion yen year-on-year.
Comprehensive income dropped sharply to 804 million yen from 8.4 billion yen year-on-year.
Full-year operating income and net income forecasts remain unchanged at 25.0 billion yen and 15.0 billion yen, respectively.
Outlook and guidance
Full-year net sales forecast remains at 410.0 billion yen, with net income projected at 25.0 billion yen, unchanged from previous guidance.
Full-year operating income is projected at 25.0 billion yen, with a V-shaped recovery expected, including a 9.0 billion yen positive impact from fundamental measures in the chloroprene rubber business.
Extraordinary losses from DPE are expected to be compensated by gains from asset sales.
Dividend policy aims to maintain or increase dividends, targeting a 50% total return ratio over the management plan period.
Latest events from Denka Company
- Mission 2030 Phase 2 targets record earnings, portfolio transformation, and sustainability.4061
Investor presentation27 Feb 2026 - Operating and net income surged despite lower sales, led by semiconductors and cost controls.4061
Q3 20266 Feb 2026 - Net sales rose but profits fell; full-year growth and stable dividends are forecast.4061
Q2 20257 Jan 2026 - Profits rose in 1H FY2025, with stable profit guidance and DPE losses offset by asset sales.4061
Q2 202610 Nov 2025 - Strong profit growth continues, but US regulatory risks for chloroprene rubber remain.4061
Q1 202513 Jun 2025 - Profit rebound is forecast after a net loss from extraordinary DPE-related losses.4061
Q4 20256 Jun 2025 - Sales up, profits down; forecasts and dividend unchanged amid regulatory risks.4061
Q3 20255 Jun 2025